186 related articles for article (PubMed ID: 17464267)
21. Somatostatin receptor SPECT.
Pepe G; Moncayo R; Bombardieri E; Chiti A
Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S41-51. PubMed ID: 22388628
[TBL] [Abstract][Full Text] [Related]
22. Feasibility and availability of ⁶⁸Ga-labelled peptides.
Decristoforo C; Pickett RD; Verbruggen A
Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S31-40. PubMed ID: 22388621
[TBL] [Abstract][Full Text] [Related]
23. PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas.
Henze M; Schuhmacher J; Hipp P; Kowalski J; Becker DW; Doll J; Mäcke HR; Hofmann M; Debus J; Haberkorn U
J Nucl Med; 2001 Jul; 42(7):1053-6. PubMed ID: 11438627
[TBL] [Abstract][Full Text] [Related]
24. Gallium and other agents in diseases of the lung.
Schuster DM; Alazraki N
Semin Nucl Med; 2002 Jul; 32(3):193-211. PubMed ID: 12105800
[TBL] [Abstract][Full Text] [Related]
25. Radiopeptides for Imaging and Therapy: A Radiant Future.
Chatalic KL; Kwekkeboom DJ; de Jong M
J Nucl Med; 2015 Dec; 56(12):1809-12. PubMed ID: 26514175
[TBL] [Abstract][Full Text] [Related]
26. A novel (68)Ga-labeled pteroic acid-based pet tracer for tumor imaging via the folate receptor.
Kühle B; Müller C; Ross TL
Recent Results Cancer Res; 2013; 194():257-67. PubMed ID: 22918763
[TBL] [Abstract][Full Text] [Related]
27. The 68Ge/ 68Ga generator has high potential, but when can we use 68Ga-labelled tracers in clinical routine?
Breeman WA; Verbruggen AM
Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):978-81. PubMed ID: 17333177
[No Abstract] [Full Text] [Related]
28. Receptor-mediated tumor targeting with radiolabeled peptides: there is more to it than somatostatin analogs.
Mariani G; Erba PA; Signore A
J Nucl Med; 2006 Dec; 47(12):1904-7. PubMed ID: 17138731
[No Abstract] [Full Text] [Related]
29. Radiolabeled carbohydrated somatostatin analogs: a review of the current status.
Wester HJ; Schottelius M; Poethko T; Bruus-Jensen K; Schwaiger M
Cancer Biother Radiopharm; 2004 Apr; 19(2):231-44. PubMed ID: 15186604
[TBL] [Abstract][Full Text] [Related]
30. Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals.
Mathias CJ; Lewis MR; Reichert DE; Laforest R; Sharp TL; Lewis JS; Yang ZF; Waters DJ; Snyder PW; Low PS; Welch MJ; Green MA
Nucl Med Biol; 2003 Oct; 30(7):725-31. PubMed ID: 14499330
[TBL] [Abstract][Full Text] [Related]
31. [Development of Molecular Probes for Live Imaging of Cancer and Infectious Diseases].
Fuchigami T
Yakugaku Zasshi; 2019; 139(12):1531-1538. PubMed ID: 31787640
[TBL] [Abstract][Full Text] [Related]
32. 'Reverse discordance' between 68Ga-DOTA-NOC PET/CT and 177Lu-DOTA-TATE posttherapy scan: the plausible explanations and its implications for high-dose therapy with radiolabeled somatostatin receptor analogs.
Basu S; Abhyankar A; Kand P; Kumar R; Asopa R; Rajan MG; Nayak U; Shimpi H; Das T; Venkatesh M; Chakrabarty S; Banerjee S
Nucl Med Commun; 2011 Jul; 32(7):654-8. PubMed ID: 21654355
[TBL] [Abstract][Full Text] [Related]
33. Gallium-labelled peptides for imaging of inflammation.
Roivainen A; Jalkanen S; Nanni C
Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S68-77. PubMed ID: 22388620
[TBL] [Abstract][Full Text] [Related]
34. Somatostatin receptors as targets for nuclear medicine imaging and radionuclide treatment.
Maecke HR; Reubi JC
J Nucl Med; 2011 Jun; 52(6):841-4. PubMed ID: 21571797
[TBL] [Abstract][Full Text] [Related]
35. Automated Synthesis of 68Ga-DOTA-TOC with a Cationic Purification System: Evaluation of Methodological and Technical Aspects in Routine Preparations.
Uccelli L; Boschi A; Cittanti C; Martini P; Lodi L; Zappaterra E; Romani S; Zaccaria S; Cecconi D; Rambaldi I; Santi I; Panareo S; Giganti M; Bartolomei M
Curr Radiopharm; 2018; 11(2):130-137. PubMed ID: 29745348
[TBL] [Abstract][Full Text] [Related]
36. PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide.
Wester HJ; Schottelius M; Scheidhauer K; Meisetschläger G; Herz M; Rau FC; Reubi JC; Schwaiger M
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):117-22. PubMed ID: 12483418
[TBL] [Abstract][Full Text] [Related]
37. The diversity of (68)Ga-based imaging agents.
Velikyan I
Recent Results Cancer Res; 2013; 194():101-31. PubMed ID: 22918757
[TBL] [Abstract][Full Text] [Related]
38. Importance of PET with
Paganelli G; Matteucci F
J Nucl Med; 2020 Dec; 61(Suppl 2):187S-188S. PubMed ID: 33293439
[No Abstract] [Full Text] [Related]
39. Generator breakthrough and radionuclidic purification in automated synthesis of 68Ga-DOTANOC.
Belosi F; Cicoria G; Lodi F; Malizia C; Fanti S; Boschi S; Marengo M
Curr Radiopharm; 2013 Jun; 6(2):72-7. PubMed ID: 23808765
[TBL] [Abstract][Full Text] [Related]
40. A methodical 68Ga-labelling study of DO2A-(butyl-L-tyrosine)2 with cation-exchanger post-processed 68Ga: practical aspects of radiolabelling.
Riss PJ; Burchardt C; Roesch F
Contrast Media Mol Imaging; 2011; 6(6):492-8. PubMed ID: 22144027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
